3D Drug Response & Resistance Profiling

A translational profiling service designed to evaluate therapeutic response and resistance behavior in human-relevant 3D tumor models.

NAMina Bio supports drug-response studies using 3D tumor model workflows compatible with quantitative viability analysis, imaging-based phenotyping, and optional molecular readouts.

This service may include:

• Experimental design for single-agent or combination treatment testing• Dose-response planning and treatment schedule design• 3D tumor model preparation or integration with an existing qualified model• Viability, morphology, and phenotypic response analysis• Optional immunofluorescence, RNA/protein recovery, or omics integration• Comparative interpretation of response and resistance patterns• Translational decision report with ranked findings and recommended next steps

Best for: biotech, pharma, and academic teams evaluating drug candidates, resistance mechanisms, tumor microenvironment effects, or patient-derived model responses.

Deliverable: a decision-ready research report summarizing model behavior, treatment response, assay limitations, and recommended follow-up experiments.

Research use only. This service is not a diagnostic test and does not provide clinical treatment recommendations.